72
V
aclavik
et al
.:
J
ournal of
AOAC I
nternational
V
ol
.
99, N
o
.
1, 2016
References
(1) Cole, M.R. & Fetrow, C.W
. (2003) Am. J. Health-System Pharm. 60 , 1576–1580(2) Vaclavik, L., Krynitsky, A.J., & Rader, J.I.
(2014) Anal. Bioanal. Chem. 406 , 6767–6790(3) Venhuis, B.J. & de Kaste, D. (2012)
J. Pharm. Biomed. Anal.
69
, 196–208
(4) Patel, D.N., Li, L., Kee, C.L., Ge, X., Low, M.Y., & Koh, H.L.
(2014)
J. Pharm. Biomed. Anal.
87
, 176–190
(5)
Standard Method Performance Requirements
2014.010
2014.011
(2015) J. AOAC Int. 98 , 1060.doi:10.5740/jaoac.int.
SMPR2014.010
(6)
Standard Method Performance Requirements
2014.011
(2015) J. AOAC Int. 98 , 1064.doi:10.5740/jaoac.int.
SMPR2014.011
(7)
Standard Method Performance Requirements
2014.012
(2015) J. AOAC Int. 98 , 1068.doi:10.5740/jaoac.int.SMPR2014.012
(8)
Official Methods of Analysis
(2005) 18th Ed., AOAC
INTERNATIONAL, Gaithersburg, MD, Appendix B:
Laboratory Safety
(9) Commission of the European Communities (2002) European
Commission Decision 2002/657/EC of August 12, 2002
implementing Council Directive 96/23/EC concerning the
performance of analytical methods and the interpretation of results,
Off. J. Eur. Communitie
s . http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2002:221:0008:0036:EN:PDFCandidates for 2016 Method of the Year
173